Announcements Trials
Browse Landscape

Status

Completed 8

Sponsor Class

INDUSTRY 5OTHER 3

Study Type

Interventional 229Observational 8Expanded_access 1

Sponsor

Cancer Type

Genitourinary 7Sarcoma 1

Conditions

Carcinoma, Renal Cell 7Financial Stress 2Sarcoma 1Coronary Artery Disease 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Observational × pazopanib × Clear all
NCT02184416 2026-02-27

ADONIS

Pfizer

Completed
554 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01649778 2020-07-15

PRINCIPAL

Novartis

Completed
662 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03519542 2019-09-18

SOGANG

Spanish Oncology Genito-Urinary Group

Completed
62 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02282579 2018-04-26

SPAZO

Spanish Oncology Genito-Urinary Group

Completed
300 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01995981 2017-12-19

PREDICT

Radboud University Medical Center

Completed
22 enrolled
Sarcoma

Sarcoma

NCT01446224 2015-03-27

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Coronary Artery Disease

NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡